West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
218.87
-0.13 (-0.06%)
At close: Jun 27, 2025, 4:00 PM
219.00
+0.13 (0.06%)
After-hours: Jun 27, 2025, 7:43 PM EDT
WST Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for WST stock ranges from a low of $245 to a high of $400. The average analyst price target of $331.67 forecasts a 51.54% increase in the stock price over the next year.
Price Target: $331.67 (+51.54%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for WST stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Initiates $245 | Hold | Initiates | $245 | +11.94% | Jun 24, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $275 | Buy | Initiates | $275 | +25.65% | Mar 18, 2025 |
| Keybanc | Keybanc | Buy Maintains $470 → $325 | Buy | Maintains | $470 → $325 | +48.49% | Feb 14, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $400 | Strong Buy | Initiates | $400 | +82.76% | Jan 8, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $350 → $355 | Strong Buy | Maintains | $350 → $355 | +62.20% | Dec 13, 2024 |
Financial Forecast
Revenue This Year
2.99B
from 2.89B
Increased by 3.38%
Revenue Next Year
3.17B
from 2.99B
Increased by 5.85%
EPS This Year
6.36
from 6.69
Decreased by -4.97%
EPS Next Year
7.21
from 6.36
Increased by 13.38%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.1B | 3.3B | 3.6B | ||
| Avg | 3.0B | 3.2B | 3.4B | ||
| Low | 2.9B | 3.0B | 3.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.0% | 11.6% | 12.3% | ||
| Avg | 3.4% | 5.9% | 6.6% | ||
| Low | -0.2% | 1.0% | 0.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.84 | 8.03 | 9.83 | ||
| Avg | 6.36 | 7.21 | 8.40 | ||
| Low | 6.10 | 6.62 | 7.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.2% | 26.3% | 36.3% | ||
| Avg | -5.0% | 13.4% | 16.5% | ||
| Low | -8.9% | 4.2% | 0.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.